Growth Metrics

Arcturus Therapeutics Holdings (ARCT) Asset Writedowns and Impairment (2024 - 2025)

Arcturus Therapeutics Holdings (ARCT) has disclosed Asset Writedowns and Impairment for 1 consecutive years, with $1.3 million as the latest value for Q1 2024.